Concepedia

David Riddell

DR

4

Publications

171

Citations

4

H-Index

1972

Active since

Affiliations

Essex Cardiothoracic Centre(Current)

David Riddell is an author at Essex Cardiothoracic Centre specializing in drug discovery, medicine, and pharmacology.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryNatural SciencesMedicinal ChemistryMolecular PharmacologyToxicologyNeuroscienceLipid Science

Publications per year

1972–1996

4

Publications

4

A comparison of the pharmacological and biochemical properties of substrate‐selective monoamine oxidase inhibitors

A.J. Christmas, C.J. Coulson, Douglas Maxwell et al. · British Journal of Pharmacology · 1972 · 93 citations · Full text

Locomotor Activity, Pharmacotherapy, Experimental Pharmacology +19

Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol

David Riddell, Colin Bright, Brenda J. Burton et al. · Biochemical Pharmacology · 1996 · 34 citations

Hypolipidaemic Properties, Oxysterol, Biochemistry +7

RP 70676: A potent systematically available inhibitor of acyl-CoA:cholesterol O-acyl transferase (ACAT)

Michael J. Ashton, A. W. BRIDGE, Raymond C. Bush et al. · Bioorganic & Medicinal Chemistry Letters · 1992 · 27 citations

Molecular Pharmacology, Medicinal Chemistry, Oxysterol +11

Acyl-CoA:Cholesterol<i>O</i>-Acyltransferase (ACAT) Inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1<i>H</i>-imidazoles as Potent Inhibitors of ACAT

Peter C. Astles, Michael J. Ashton, Andrew W. Bridge et al. · Journal of Medicinal Chemistry · 1996 · 17 citations · Full text

Rows per page

1–4 of 4